These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38924283)

  • 1. The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis.
    Calderon Martinez E; Zachariah Saji S; Salazar Ore JV; Borges-Sosa OA; Srinivas S; Mareddy NSR; Manzoor T; Di Vanna M; Al Shanableh Y; Taneja R; Arruarana VS
    Neuropsychopharmacol Rep; 2024 Sep; 44(3):545-556. PubMed ID: 38924283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
    Eur J Prev Cardiol; 2024 Nov; 31(15):1863-1875. PubMed ID: 38869144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Souvenaid®: a new approach to management of early Alzheimer's disease.
    Ritchie CW; Bajwa J; Coleman G; Hope K; Jones RW; Lawton M; Marven M; Passmore P
    J Nutr Health Aging; 2014 Mar; 18(3):291-9. PubMed ID: 24626757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
    J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids and cognitive function.
    Welty FK
    Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
    Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
    Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and metabolic effects of omega-3 polyunsaturated fatty acid supplementation and the role of β-hydroxy-β-methylbutyrate addition in chronic obstructive pulmonary disease: A randomized clinical trial.
    Engelen MPKJ; Simbo SY; Ruebush LE; Thaden JJ; Ten Have GAM; Harrykissoon RI; Zachria AJ; Calder PC; Pereira SL; Deutz NEP
    Clin Nutr; 2024 Sep; 43(9):2263-2278. PubMed ID: 39181037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of omega-3 fatty acid DHA and EPA supplementation in pregnant or breast-feeding women on cognitive performance of children: systematic review and meta-analysis.
    Lehner A; Staub K; Aldakak L; Eppenberger P; Rühli F; Martin RD; Bender N
    Nutr Rev; 2021 Apr; 79(5):585-598. PubMed ID: 32918470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW.
    de Souza Fernandes DP; Canaan Rezende FA; Pereira Rocha G; De Santis Filgueiras M; Silva Moreira PR; Gonçalves Alfenas Rde C
    Nutr Hosp; 2015 Aug; 32(2):528-33. PubMed ID: 26268080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ω-3 fatty acids in the prevention of cognitive decline in humans.
    Cederholm T; Salem N; Palmblad J
    Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
    Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
    Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of long-chain n-3 polyunsaturated fatty acid supplementation on tuberculosis in mice.
    Nienaber A; Ozturk M; Dolman RC; Zandberg L; Hayford FE; Brombacher F; Blaauw R; Smuts CM; Parihar SP; Malan L
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jul; 170():102304. PubMed ID: 34082319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.
    Onakpoya IJ; Heneghan CJ
    Nutr Neurosci; 2017 May; 20(4):219-227. PubMed ID: 26638900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
    McDonnell SL; French CB; Baggerly CA; Harris WS
    Nutr Res; 2019 Nov; 71():43-55. PubMed ID: 31757628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.